Continuous glucose sensor study after kidney transplant
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- You had a kidney transplant within the last year, and your kidney function is fairly preserved (eGFR above 30)
- You have type 2 diabetes and take insulin
- You have home Wi‑Fi to connect the monitoring device
- You must be able to wear the Dexcom G6 sensor all the time
- You must be able to do finger-stick blood sugar testing 4 times per day during the monitoring period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a small sensor called a continuous glucose monitor (CGM) that tracks your blood sugar after kidney transplant. It helps doctors see how your body handles sugar during recovery.
This study tests whether using a real-time continuous glucose monitor (a device that tracks your blood sugar continuously) helps improve blood sugar control in people with type 2 diabetes who also have chronic kidney disease (stages 3 and 4). If you qualify, you may get better insight into your glucose patterns, which could help you manage your diabetes more effectively.
This study tests whether continuous glucose monitors (CGMs) work accurately in people doing peritoneal dialysis with icodextrin solution. It may help you manage your diabetes better by showing your glucose levels in real time.
This study compares two ways to monitor blood sugar after partial or full pancreas removal: a continuous glucose sensor versus traditional finger-stick testing. It looks at both how well blood sugar is controlled and how satisfied people feel with each method.
This study tests a continuous glucose monitor (a sensor that tracks glucose) for people with type 1 or type 2 diabetes who receive care at home through Mayo’s Advanced Care at Home program. It may help by improving how safely and accurately blood sugar is followed while you’re at home.
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
Hear when a new Kidney Transplant; Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.